Author: Rhein, Bethany A.; Powers, Linda S.; Rogers, Kai; Anantpadma, Manu; Singh, Brajesh K.; Sakurai, Yasuteru; Bair, Thomas; Miller-Hunt, Catherine; Sinn, Patrick; Davey, Robert A.; Monick, Martha M.; Maury, Wendy
Title: Interferon-? Inhibits Ebola Virus Infection Document date: 2015_11_12
ID: 10bu7iwg_22
Snippet: To assess the impact of IFNγ treatment on cells at the site of infection, peritoneal cells were isolated 24 hours following EBOV GP/rVSV infection of untreated or IFNγ-treated mice. IFNγ treated peritoneal cells had reduced viral RNA levels compared to infected, PBS-treated control cells, regardless of whether IFNγ was given 24 hours prior to, 2, 6 or 12 hours following challenge. These findings suggest that active infection at the site of ch.....
Document: To assess the impact of IFNγ treatment on cells at the site of infection, peritoneal cells were isolated 24 hours following EBOV GP/rVSV infection of untreated or IFNγ-treated mice. IFNγ treated peritoneal cells had reduced viral RNA levels compared to infected, PBS-treated control cells, regardless of whether IFNγ was given 24 hours prior to, 2, 6 or 12 hours following challenge. These findings suggest that active infection at the site of challenge is ongoing at 24 hours following infection and that IFNγ administration either before or at early time points following infection is able to profoundly reduce virus load at the site of virus challenge (Fig 5C) .
Search related documents:
Co phrase search for related documents- active infection and early time: 1, 2
- active infection and infection follow: 1, 2, 3, 4, 5, 6, 7, 8, 9
- active infection and infection site: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- challenge site and infection site: 1, 2
- control cell and EBOV GP rvsv: 1
- control cell and EBOV GP rvsv infection: 1
- control cell and GP rvsv: 1
- control cell and infection site: 1
- early time and infection follow: 1
- early time and infection site: 1, 2, 3
- EBOV GP rvsv and GP rvsv: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- EBOV GP rvsv and IFNγ administration: 1, 2
- EBOV GP rvsv and IFNγ treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- EBOV GP rvsv and peritoneal cell: 1
- EBOV GP rvsv infection and GP rvsv: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- EBOV GP rvsv infection and IFNγ administration: 1, 2
- EBOV GP rvsv infection and IFNγ treatment: 1, 2, 3, 4, 5, 6, 7
- GP rvsv and IFNγ administration: 1, 2
- GP rvsv and IFNγ treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
Co phrase search for related documents, hyperlinks ordered by date